S. Huhtala

Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition

R. Huupponen, M. Scheinin, E. Savontaus, 1999, European Journal of Clinical Pharmacology.

Management of Testicular Cancer: 16 years' Experience from Southwest Finland

J. Toppari, M. Laato, E. Salminen, 2001, Scandinavian journal of urology and nephrology.

A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjects

R. Huupponen, H. Scheinin, E. Salminen, 1999, European Journal of Clinical Pharmacology.

Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.

R. Luoto, M. Koskenvuo, T. Backman, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation‐wide study of 17,360 users

R. Luoto, T. Backman, I. Rauramo, 2000, BJOG : an international journal of obstetrics and gynaecology.

Pregnancy during the use of levonorgestrel intrauterine system.

M. Koskenvuo, T. Backman, I. Rauramo, 2004, American journal of obstetrics and gynecology.

Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with Radiotherapy

H. Haapasalo, L. Talve, E. Salminen, 2004, Journal of Neuro-Oncology.

Advance Information Improves User Satisfaction With the Levonorgestrel Intrauterine System

R. Luoto, M. Koskenvuo, T. Backman, 2002, Obstetrics and gynecology.

Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland

R. Luoto, M. Koskenvuo, T. Backman, 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas

K. Någren, H. Minn, P. Lindholm, 1998, European Journal of Nuclear Medicine.

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

E. Salminen, J. Nuutinen, S. Huhtala, 1996, European journal of cancer.

Docetaxel: standard recommended dose of 100 mg/m(2) is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study.

E. Salminen, M. Bergman, Sakke Huhtala, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.